July 31, 2014 / 12:40 PM / 3 years ago

BRIEF-Teva 2014 revenue outlook

1 Min Read

July 31 (Reuters) - Teva Pharmaceutical Industries Ltd said:

* Sees 2014 revenue $19.5-$20.5 billion with Copaxone competition versus previous estimate $19.3-$20.3 billion Further company coverage: (Reporting by Tova Cohen)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below